References
- Mattoni A, Bellucco A, Canova N, Pannuti F. Four-year analysis of platinum and anthracycline combination for ovarian cancer. Oncology 1989; 46: 109-116.
- Sutton G, Stehman FB, Ehrlich C. Chemotherapy of epithelial ovarian cancer. In: Piver MS ed. Ovarian Malignancies Diagnostic and Therapeutic Advances. Edinburgh London Melbourne and New York: Churchill Livingstone 1987; 163-185.
- Thigpen T, Vance R, Lambuth B et al. Chemotherapy for advanced or recurrent gynecologic cancer. Cancer 1987; 60: 2104-2116.
- Goldie JH, Coldman AJ. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 1979; 63: 1727-1733.
- Goldie JH, Coldman AJ, Gudauskas GA. Rationale for the use of alternating non-cross-resistant chemotherapy. Cancer Treat Rep. 1982; 66: 439-449.
- Curtler SJ, Ederer F. Maximum utilization of the life-table method in analyzing survival. J Chron Dis, 1958; 8: 699-713.
- Breslow N. A generalized Kruskal-Wallis test for comparing k samples subject to unequal patterns of censorship. Biometrika 1970; 57: 579-594.
- Fisher RA. The use of multiple measurements in taxonomic problems. Ann Eugen 1936; 7: 179-188.
- Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207-214.
- Levin L, Hryniuk WM. Dose intensity analysis of chemotherapy regimens in ovarian carcinoma. J Clin Oncol 1987; 5 (5): 756-767.
- Neijt JP, ten Bokkel Huinink WW, van der Burg MEL et al. Randomised trial comparing two combination chemotherapy regimens (Hexa-CAF vs. CHAP-5) in advanced ovarian carcinoma. Lancet 1984; 2: 594-600.
- Piccard MJ, Speyer JL, Wernz JC, et al. Advanced ovarian cancer: Three-year results of a (6-8 month) 2 drug cisplatin containing regimen. Eur J Cancer Clin Oncol. 1987; 23: 631-641.
- Ozols RF, Behrens BC, Ostchega F, Young RC. High dose cisplatin and high dose carboplatin in refractory ovarian cancer. Cancer Treat Rev. 1985; 12 (suppl. A), 59-65.
- Bruckner HW, Wallach R, Cohen CJ, et al. High-dose platinum for the treatment of refractory ovarian cancer. Gynecol Oncol 1981; 12: 64-67.
- Barker GH, Wiltshaw E. Use of high dose cis-dichlor-odiammineplatinum (II) (NSC 119875) following failure on previous chemotherapy for advanced carcinoma of the ovary. Br J Obstet Gynaecol 1981; 88: 1192-1199.